Trevena trevenainc.com


Public list: BIO 2016 (619) Smart Money VCs (6327) Pharma Startups (4743)

Trevena is a clinical stage pharmaceutical company focused on discovering and developing the next generation of G protein coupled receptor (GPCR) targeted medicines. Despite the past success of GPCR drugs, there is a significant opportunity to enhance their therapeutic properties by specifically activating or deactivating selected receptor-mediated signals. Trevena's expertise lies in understanding which signaling pathways downstream of a GPCR are associated with beneficial versus adverse biolog...Show all

Trevena is a clinical stage pharmaceutical company focused on discovering and developing the next generation of G protein coupled receptor (GPCR) targeted medicines. Despite the past success of GPCR drugs, there is a significant opportunity to enhanc...Show all

Company (IPO / Went public)

Phone: 610-354-8840

Fax:

1018 West 8th Avenue
Suite A
King Of Prussia, 19406
Pennsylvania, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Trevena $129M Jan 31, 2014
Threshold Pharmaceuticals $106.4M Aug 2, 2017
VLST Corporation $67.9M Aug 7, 2013
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Trevena Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 7 investors

Competitors

Company Status Description Investors
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Opioid receptor ligands and methods of using and making same Mar 29, 2017 Dec 26, 2017 Patent
Opioid receptor ligands and methods of using and making same Apr 07, 2016 May 09, 2017 Patent
Synthesis of beta-arrestin effectors May 19, 2015 Apr 04, 2017 Patent
Beta-arrestin effectors and compositions and methods of use thereof Aug 15, 2014 Jan 03, 2017 Patent
Crystalline and amorphous forms of a β-arrestin effector Feb 06, 2015 Dec 13, 2016 Patent
See all 20 patents